APA

Torres-Bugarín O., Ventura-Aguilar A., Zamora-Perez A., Gómez-Meda B. C., Ramos-Ibarra M. L., Morgan-Villela G., Gutiérrez-Franco A. & Zúñiga-González G. (20031008). Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa. : Mutation research.

Chicago

Torres-Bugarín O, Ventura-Aguilar A, Zamora-Perez A, Gómez-Meda B C, Ramos-Ibarra M L, Morgan-Villela G, Gutiérrez-Franco A and Zúñiga-González G. 20031008. Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa. : Mutation research.

Harvard

Torres-Bugarín O., Ventura-Aguilar A., Zamora-Perez A., Gómez-Meda B. C., Ramos-Ibarra M. L., Morgan-Villela G., Gutiérrez-Franco A. and Zúñiga-González G. (20031008). Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa. : Mutation research.

MLA

Torres-Bugarín O, Ventura-Aguilar A, Zamora-Perez A, Gómez-Meda B C, Ramos-Ibarra M L, Morgan-Villela G, Gutiérrez-Franco A and Zúñiga-González G. Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa. : Mutation research. 20031008.